A phase I/II study of neoadjuvant liposomal doxorubicin, paclitaxel, and hyperthermia in locally advanced breast cancer

PURPOSE: The prognosis for locally advanced breast cancer (LABC) patients continues to be poor, with an estimated five-year survival of only 50–60%. Preclinical data demonstrates enhanced therapeutic efficacy with liposomal encapsulation of doxorubicin combined with hyperthermia (HT). Therefore this...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Vujaskovic, Zeljko, Kim, Dong W., Jones, Ellen, Lan, Lan, McCall, Linda, Dewhirst, Mark W., Craciunescu, Oana, Stauffer, Paul, Liotcheva, Vlayka, Betof, Allison, Blackwell, Kimberly
Формат: Artigo
Язык:Inglês
Опубликовано: 2010
Предметы:
Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC2956498/
https://ncbi.nlm.nih.gov/pubmed/20377362
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3109/02656731003639364
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы